ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,764.72
-0.49%
Dow Jones
44,711.43
0.77%
Gold vs US Dollar
2,932.985
0.06%
Brent Oil
75.035
-0.07%
Bitcoin
96,769.93
0.16%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. GT Biopharma Inc (GTBP)

  7. GT Biopharma Inc (GTBP) News

GT Biopharma (GTBP)

GT Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GTBP
DateTimeSourceHeadlineSymbolCompany
07/02/202514:32Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:GTBPGT Biopharma Inc
27/01/202513:31Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:GTBPGT Biopharma Inc
27/01/202512:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
23/12/202422:23Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:GTBPGT Biopharma Inc
27/11/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
21/11/202414:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
14/11/202421:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
22/10/202401:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
17/10/202415:15Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:GTBPGT Biopharma Inc
16/09/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
17/06/202420:26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
13/06/202420:14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
07/06/202421:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
24/05/202400:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GTBPGT Biopharma Inc
23/05/202410:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GTBPGT Biopharma Inc
23/05/202410:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
15/05/202421:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
14/02/202419:46Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GTBPGT Biopharma Inc
01/02/202417:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
21/12/202320:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
04/12/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
06/11/202322:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
06/11/202322:23Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
06/11/202322:21Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GTBPGT Biopharma Inc
01/11/202313:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
27/10/202321:23Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GTBPGT Biopharma Inc
19/09/202315:56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GTBPGT Biopharma Inc
22/08/202320:55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
15/08/202323:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
15/08/202323:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:GTBP

Your Recent History

LSE
SFOR
S4 Capital
LSE
GDR
Genedrive
LSE
BOO
Boohoo
LSE
GPM
Golden Prospect Precious...
LSE
PANR
Pantheon Resources
LSE
MPE
M.p. Evans
LSE
BIRD
Blackbird
LSE
LPA
Lpa
LSE
YU.
Yu
LSE
SRSP
Sirius Petroleum
LSE
ITM
Itm Power
LSE
ULT
Ultrasis
LSE
GEX
Georgina Energy
LSE
MATD
Petro Matad
LSE
IQE
Iqe
LSE
DGI9
Digital 9 Infrastructure
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads